ArticleEye (London, England)2024

Voretigene neparvovec for inherited retinal dystrophy due to RPE65 mutations: a scoping review of eligibility and treatment challenges from clinical trials to real practice.

Francesco Testa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.